The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery - A randomised study

European Journal of Cardio-thoracic Surgery

Volumn 13, Issue 1, 1998, Pages 42-48

  Webb, Carolyn M ^a   Underwood, Richard ^b   Anagnostopoulos, Constantinos ^b   Bennett, J Graeme ^b   Pepper, John ^b   Lincoln, Christopher ^b   Collins, Peter ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; QUINAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CELL VIABILITY; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; ENZYME INHIBITION; FEMALE; HEART FUNCTION; HUMAN; INOTROPISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; VASCULAR RESISTANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; PREOPERATIVE CARE; STROKE VOLUME; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 0031893978     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)00284-4     Document Type: Article

References (29)

1. Rahimtoola SH. Coronary bypass surgery for chronic angina - 1981. A perspective. Circulation. 65:1982;225-241.
2. Ross RS. Ischemic heart disease: an overview. Am J Cardiol. 36:1975;496-505.
3. Taylor NC, Barber RW, Crossland P, English TA, Wraight EP, Petch MC. Effects of coronary artery bypass grafting on left ventricular function assessed by multiple gated ventricular scintigraphy. Br Heart J. 50:1983;149-156.
4. Wolf NM, Kreulen TH, Bove AA et al. Left ventricular function following coronary bypass surgery. Circulation. 58:1978;63-70.
5. Hammermeister KE, Kennedy JW, Hamilton GW et al. Aortocoronary saphenous-vein bypass. Failure of successful grafting to improve resting left ventricular function in chronic angina. New Engl J Med. 290:1974;186-192.
6. Nelson GR, Cohn PF, Gorlin R. Prognosis in medically-treated CAD: influence of ejection fraction compared to other parameters. Circulation. 52:1975;408-412.
7. Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 68:1983;785-795.
8. Effects of enalapril on mortality in severe congestive heart failure. Results of the CONSENSUS. New Engl J Med. 316:1987;1429-1435.
9. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med. 325:1991;293-302.
10. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the CONSENSUS II. New Engl J Med. 327:1992;678-684.
11. Pfeffer MA, Braunwald E, Moy LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. New Engl J Med. 327:1992;669-677.
12. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The AIRE study investigators. Lancet. 342:1993;821-828.
13. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 343:1994;1115-1122.
14. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of myocardial infarction long-term evaluation (SMILE) study investigators. New Engl J Med. 332:1995;80-85.
15. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685.
16. Ertl G, Kloner RA, Alexander RW, Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation. 65:1982;40-48.
17. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. 1990;Arnold, London.
18. Favre L, Vallotton MB, Muller AF. Relationship between plasma concentrations of angiotensin-I, angiotensin-II and plasma renin activity during cardio-pulmonary bypass in man. Eur J Clin Invest. 4:1974;135-140.
19. Roberts AJ, Niarchos AP, Subramanian VA et al. Systemic hypertension associated with coronary artery bypass surgery. Pre-disposing factors, hemodynamic characteristics, humoral profile and treatment. J Thorac Cardiovasc Surg. 74:1977;846-859.
20. Taylor KM, Morton IJ, Brown JJ, Bain WH, Caves PK. Hypertension and the renin-angiotensin system following open-heart surgery. J Thorac Cardiovasc Surg. 74:1977;840-845.
21. Taylor KM, Bain WH, Morton JJ. The role of angiotensin-II in the development of peripheral vasoconstriction during open-heart surgery. Am Heart J. 100(6):1980;935-937.
22. Taylor KM, Casals JG, Mittra SM, Brannan JJ, Morton JJ. Haemodynamic effects of angiotensin converting enzyme inhibition after cardiopulmonary bypass in dogs. Cardiovasc Res. 14:1980;199-205.
23. Gavras H, Kremer D, Brown JJ et al. Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J. 89:1975;321-332.
24. de Graeff PA, van Gilst WH, Bel K, de Langen CD, Kingma JH, Wesseling H. Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model. J Cardiovasc Pharmacol. 9(2):1987;S37-S42.
25. Di Pasquale P, Paterna S, Valenza M et al. Effects of captopril on myocardial protection during cardioplegia. Int J Cardiol. 42:1993;225-230.
26. van Gilst WH, Scholtens E, de Graeff PA, de Langen CD, Wesseling H. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation. Circulation. 77:1988;I24-I29.
27. Linz W, Scholkens BA, Han YF. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol. 8(10):1986;S91-S99.
28. Linz W, Scholkens BA. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the anti-hypertrophic effect of ramipril. Br J Pharmacol. 105:1992;771-772.
29. Przyklenk K, Kloner RA. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action. Am Heart J. 121:1991;1319-1330.